Universal Health Services/$UHS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Universal Health Services
Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two segments: Acute Care Hospital Services and Behavioral Health Services. The company generates the majority of its revenue from the Acute Care Hospital Services segment. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.
Ticker
$UHS
Sector
Primary listing
NYSE
Employees
87,500
Headquarters
Website
UHS Metrics
BasicAdvanced
$12B
9.89
$18.95
1.24
$0.80
0.43%
Price and volume
Market cap
$12B
Beta
1.24
52-week high
$240.67
52-week low
$152.33
Average daily volume
706K
Dividend rate
$0.80
Financial strength
Current ratio
1.29
Quick ratio
1.053
Long term debt to equity
68.494
Total debt to equity
70.09
Dividend payout ratio (TTM)
4.19%
Interest coverage (TTM)
11.25%
Profitability
EBITDA (TTM)
2,411.604
Gross margin (TTM)
42.87%
Net profit margin (TTM)
7.66%
Operating margin (TTM)
11.03%
Effective tax rate (TTM)
23.09%
Revenue per employee (TTM)
$190,000
Management effectiveness
Return on assets (TTM)
7.81%
Return on equity (TTM)
18.79%
Valuation
Price to earnings (TTM)
9.889
Price to revenue (TTM)
0.744
Price to book
1.7
Price to tangible book (TTM)
3.95
Price to free cash flow (TTM)
13.587
Free cash flow yield (TTM)
7.36%
Free cash flow per share (TTM)
13.792
Dividend yield (TTM)
0.43%
Forward dividend yield
0.43%
Growth
Revenue change (TTM)
9.61%
Earnings per share change (TTM)
39.27%
3-year revenue growth (CAGR)
8.05%
10-year revenue growth (CAGR)
6.56%
3-year earnings per share growth (CAGR)
24.33%
10-year earnings per share growth (CAGR)
12.06%
10-year dividend per share growth (CAGR)
7.18%
What the Analysts think about UHS
Analyst ratings (Buy, Hold, Sell) for Universal Health Services stock.
Bulls say / Bears say
UHS reported Q2 2025 net revenues of $4.28 billion, a 9.6% year-over-year increase driven by strong pricing and demand in both its acute and behavioral health divisions.
The company raised its full-year 2025 adjusted EPS guidance to $20.00–$21.00 and lifted its net revenue outlook to $17.1–$17.31 billion, both ahead of previous projections and consensus estimates.
UHS bought back 875,000 shares for about $150.8 million in Q2, leaving $492.9 million in remaining authorization—demonstrating management’s ongoing focus on returning capital to shareholders.
Operating cash flow fell 19.2% year-over-year to $549 million in Q2 2025, due to unfavorable working capital changes—a development that could weigh on liquidity.
The new 142-bed Cedar Hill Regional Medical Center in Washington, D.C. posted a $25 million pre-tax loss for the quarter, underscoring both execution and startup risks for new facilities.
With Medicaid supplemental payments making up roughly 68% of UHS’s pretax income, proposed GOP cuts to these programs could lower annual profits by $360–$400 million by 2032 and present significant political risk.
Data summarised monthly by Lightyear AI. Last updated on 3 Sept 2025.
UHS Financial Performance
Revenues and expenses
UHS Earnings Performance
Company profitability
UHS News
AllArticlesVideos
Behavioral Segment Concerns Overshadow Universal Health Q2 Earnings Beat
Benzinga2 months ago
Universal Health Services beats quarterly profit estimates on higher medical care demand
Reuters2 months ago
S&P 500 Gains and Losses Today: Johnson & Johnson Stock Jumps; Universal Health Services Shares Slide
Investopedia2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Universal Health Services stock?
Universal Health Services (UHS) has a market cap of $12B as of September 18, 2025.
What is the P/E ratio for Universal Health Services stock?
The price to earnings (P/E) ratio for Universal Health Services (UHS) stock is 9.89 as of September 18, 2025.
Does Universal Health Services stock pay dividends?
Yes, the Universal Health Services (UHS) stock pays dividends to shareholders. As of September 18, 2025, the dividend rate is $0.8 and the yield is 0.43%. Universal Health Services has a payout ratio of 4.18% on a trailing twelve-month basis.
When is the next Universal Health Services dividend payment date?
The next Universal Health Services (UHS) dividend payment date is unconfirmed.
What is the beta indicator for Universal Health Services?
Universal Health Services (UHS) has a beta rating of 1.24. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.